METOPROLOL TARTRATE TABLETS

The Defense Logistics Agency (DLA) issued a delivery order under contract SPE2DX25D8022 to Cardinal Health, Inc. (CAGE 00E55), a small disadvantaged women-owned business, for the procurement of one unit of METOPROLOL TARTRATE TABLETS (NSN 6505010716557) at a total price of $27.92. The award, dated July 19, 2026, reflects a low-value pharmaceutical supply under a delivery order framework, likely processed via the Lowest Price Technically Acceptable methodology due to its administrative nature and minimal scope. Delivery is required by July 20, 2026, to the USS CHARLESTON LCS 18 at FPO AP 96694, with FOB Destination terms placing all transportation costs and risk on the contractor until receipt at the destination. Packaging must use traceable shipping methods, explicitly prohibiting parcel post, and all shipments must include the contract number SPE2DX-25-D-8022, delivery order number SPE2D9-26-F-7443, and the Transport Control Number R201566179M281. The product is identified by NDC codes 00378-0032-10 and 51407-0110-10 and must comply with DLA procedural guidelines and ANSI X12 unit of issue standards, though no specific pharmaceutical quality specifications such as USP or FDA standards are detailed. Inspection and acceptance are performed by the Government at destination, with Lisa Quinn serving as the principal contracting officer and Michelle Pampel as the administrative point of contact. Payment will be processed by Defense Finance and Accounting Service at P.O. Box 182317, Columbus, OH 43218-2317, using BX code 97X4930 5CBX 001 2620 S33189. The contractor is required to use the Vendor Shipping Module for shipment tracking and adhere to government-only codes including IPD 05, DIC A4A, DIST 9B, ADV 2A, and FC N7. The award triggers subcontracting reporting obligations under FAR 52.219-28 due to the contractor’s socioeconomic